|
SPATA6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.16900045199486E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.14352971536391E-14 |
| Normal-vs-Stage2 |
6.26059999953021E-07 |
| Normal-vs-Stage3 |
1.38260514148669E-11 |
| Normal-vs-Stage4 |
2.8463997825412E-10 |
| Stage1-vs-Stage2 |
4.173200E-01 |
| Stage1-vs-Stage3 |
1.070400E-01 |
| Stage1-vs-Stage4 |
2.636400E-01 |
| Stage2-vs-Stage3 |
5.675900E-02 |
| Stage2-vs-Stage4 |
1.136430E-01 |
| Stage3-vs-Stage4 |
9.266400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.98879809790265E-11 |
| Normal-vs-AfricanAmerican |
8.495200E-03 |
| Normal-vs-Asian |
1.68189999705248E-08 |
| Caucasian-vs-AfricanAmerican |
4.118400E-03 |
| Caucasian-vs-Asian |
5.965000E-01 |
| AfricanAmerican-vs-Asian |
4.515900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.48120404830365E-11 |
| Normal-vs-Female |
4.20599999273463E-10 |
| Male-vs-Female |
7.732200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.84716694665121E-12 |
| Normal-vs-Age(41-60Yrs) |
9.1251006750781E-11 |
| Normal-vs-Age(61-80Yrs) |
8.07810041081325E-10 |
| Normal-vs-Age(81-100Yrs) |
2.236900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.518400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.408000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.408400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.554800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.886600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.503400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.723400E-03 |
| Classical-VS-Follicular |
2.095000E-01 |
| Classical-VS-Other |
7.016200E-01 |
| Classical-VS-Normal |
1.07450004449561E-09 |
| Tall-VS-Follicular |
1.976360E-03 |
| Tall-VS-Other |
4.267400E-01 |
| Tall-VS-Normal |
6.58051391155823E-12 |
| Follicular-VS-Other |
4.646800E-01 |
| Follicular-VS-Normal |
4.65189999854232E-08 |
| Other-VS-Normal |
3.876300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.99280649946377E-14 |
| Normal-vs-N1 |
5.12410003317143E-10 |
| N0-vs-N1 |
3.353800E-01 |
|
|
